Literature DB >> 17316084

Monoclonal antibodies against LipL32, the major outer membrane protein of pathogenic Leptospira: production, characterization, and testing in diagnostic applications.

Cláudia P H Fernandes1, Fabiana K Seixas, Mariana L Coutinho, Flávia A Vasconcellos, Núbia Seyffert, Julio Croda, Alan J McBride, Albert I Ko, Odir A Dellagostin, José A G Aleixo.   

Abstract

Pathogenic serovars of Leptospira have a wide antigenic diversity attributed mainly to the lipopolysaccharide present in the outer membrane. In contrast, antigens conserved among pathogenic serovars are mainly represented by outer membrane proteins. Surface exposure of a major and highly conserved outer membrane lipoprotein (LipL32) was recently demonstrated on pathogenic Leptospira. LipL32 in its recombinant form (rLipL32) was used to immunize BALB/c mice to develop murine monoclonal antibodies (MAbs). Three MAbs against rLipL32 were produced, isotyped, and evaluated for further use in diagnostic tests of leptospirosis using different approaches. MAbs were conjugated to peroxidase and evaluated in a native protein enzyme-linked immunosorbent assay (ELISA) with intact and heat-treated leptospiral cells, conjugated to fluorescein isothiocyanate (FITC) for indirect immunofluorescence with intact and methanol fixed cells and were used for LipL32 immunoprecipitation from leptospiral cells. rLipL32 MAbs conjugated to peroxidase or used as primary antibody bound to intact and heat-treated cells in ELISA, proving that they could be used in enzyme immunoassays for detection of the native protein. In immunofluorescence assay, MAbs labeled bacterial cells either intact or methanol fixed. Two MAbs were able to immunoprecipitate the native protein from live and motile leptospiral cells and, adsorbed onto magnetic beads, captured intact bacteria from artificially contaminated human sera for detection by polymerase chain reaction (PCR) amplification. Results of this study suggest that the MAbs produced can be useful for the development of diagnostic tests based on detection of LipL32 leptospiral antigen in biological fluids.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17316084     DOI: 10.1089/hyb.2006.033

Source DB:  PubMed          Journal:  Hybridoma (Larchmt)        ISSN: 1554-0014


  10 in total

1.  Phenotypic and Molecular Characterization of Leptospira interrogans Isolated from Canis familiaris in Southern Brazil.

Authors:  Sérgio Jorge; Leonardo G Monte; Natasha R De Oliveira; Thais F Collares; Bárbara C Roloff; Charles K Gomes; Daiane D Hartwig; Odir A Dellagostin; Cláudia P Hartleben
Journal:  Curr Microbiol       Date:  2015-06-23       Impact factor: 2.188

2.  Pathogen-specific leptospiral proteins in urine of patients with febrile illness aids in differential diagnosis of leptospirosis from dengue.

Authors:  R Chaurasia; K C Thresiamma; C K Eapen; B J Zachariah; R Paul; M Sritharan
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-01-13       Impact factor: 3.267

3.  Protection against lethal leptospirosis after vaccination with LipL32 coupled or coadministered with the B subunit of Escherichia coli heat-labile enterotoxin.

Authors:  André A Grassmann; Samuel R Félix; Carolina Ximendes dos Santos; Marta G Amaral; Amilton C P Seixas Neto; Michel Q Fagundes; Fabiana K Seixas; Everton F da Silva; Fabricio R Conceição; Odir A Dellagostin
Journal:  Clin Vaccine Immunol       Date:  2012-02-29

4.  The OmpL37 surface-exposed protein is expressed by pathogenic Leptospira during infection and binds skin and vascular elastin.

Authors:  Marija Pinne; Henry A Choy; David A Haake
Journal:  PLoS Negl Trop Dis       Date:  2010-09-07

5.  Characterization of a virulent Leptospira interrogans strain isolated from an abandoned swimming pool.

Authors:  Karine M Forster; Daiane D Hartwig; Fabiana K Seixas; Alan J A McBride; Leonardo G Monte; Ana Lúcia C Recuero; Claudiomar S Brod; Cláudia P Hartleben; Marta Amaral; Odir A Dellagostin
Journal:  Braz J Microbiol       Date:  2013-05-14       Impact factor: 2.476

6.  A Universal Vaccine against Leptospirosis: Are We Going in the Right Direction?

Authors:  André Alex Grassmann; Jéssica Dias Souza; Alan John Alexander McBride
Journal:  Front Immunol       Date:  2017-03-09       Impact factor: 7.561

7.  LipL32 Is a Subsurface Lipoprotein of Leptospira interrogans: presentation of new data and reevaluation of previous studies.

Authors:  Marija Pinne; David A Haake
Journal:  PLoS One       Date:  2013-01-08       Impact factor: 3.240

8.  Evaluation of truncated LipL32 expressed by Escherichia coli and Pichia pastoris for serodiagnosis of Leptospira infection in rodents.

Authors:  Kanae Shiokawa; Chandika D Gamage; Nobuo Koizumi; Yoshihiro Sakoda; Kenta Shimizu; Yoshimi Tsuda; Kumiko Yoshimatsu; Jiro Arikawa
Journal:  J Vet Med Sci       Date:  2015-09-27       Impact factor: 1.267

9.  Evaluation of the Leptospira interrogans Outer Membrane Protein OmpL37 as a Vaccine Candidate.

Authors:  Thaís Larré Oliveira; André Alex Grassmann; Rodrigo Andrade Schuch; Amilton Clair Pinto Seixas Neto; Marcelo Mendonça; Daiane Drawanz Hartwig; Alan John Alexander McBride; Odir Antônio Dellagostin
Journal:  PLoS One       Date:  2015-11-20       Impact factor: 3.240

Review 10.  Insight into the Structure, Functions, and Dynamics of the Leptospira Outer Membrane Proteins with the Pathogenicity.

Authors:  Shen-Hsing Hsu; Chih-Wei Yang
Journal:  Membranes (Basel)       Date:  2022-03-07
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.